These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33468471)

  • 61. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
    Barnes MD; Taracila MA; Good CE; Bajaksouzian S; Rojas LJ; van Duin D; Kreiswirth BN; Jacobs MR; Haldimann A; Papp-Wallace KM; Bonomo RA
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182530
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.
    Kaase M; Schimanski S; Schiller R; Beyreiß B; Thürmer A; Steinmann J; Kempf VA; Hess C; Sobottka I; Fenner I; Ziesing S; Burckhardt I; von Müller L; Hamprecht A; Tammer I; Wantia N; Becker K; Holzmann T; Furitsch M; Volmer G; Gatermann SG
    Int J Med Microbiol; 2016 Sep; 306(6):415-20. PubMed ID: 27237423
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
    Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
    J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
    Ouertani R; Ben Jomàa-Jemili M; Gharsa H; Limelette A; Guillard T; Brasme L; de Champs C; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):142-149. PubMed ID: 28737463
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro susceptibility of multi-drug resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from clinical specimens at Bugando Medical Centre, Tanzania to Piperacillin-Tazobactam.
    Petro D; Mushi MF; Moremi N; Iddi S; Mirambo M; Seni J; Mshana SE
    Tanzan J Health Res; 2014 Jan; 16(1):54-7. PubMed ID: 26867273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
    Bayramoğlu G; Uluçam G; Gençoğlu Özgür Ç; Kılıç AO; Aydın F
    Mikrobiyol Bul; 2016 Jan; 50(1):1-10. PubMed ID: 27058324
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
    Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments.
    Wistrand-Yuen P; Olsson A; Skarp KP; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
    Clin Microbiol Infect; 2020 Sep; 26(9):1214-1221. PubMed ID: 32224200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence of Klebsiella pneumoniae carbapenemase - and New Delhi metallo-beta-lactamase-positive K. pneumoniae in Sergipe, Brazil, and combination therapy as a potential treatment option.
    Vivas R; Dolabella SS; Barbosa AAT; Jain S
    Rev Soc Bras Med Trop; 2020; 53():e20200064. PubMed ID: 32401864
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a new spectrophotometric assay for rapid detection and differentiation of KPC, MBL and OXA-48 carbapenemase-producing Klebsiella pneumoniae clinical isolates.
    Routsias JG; Tsakogiannis D; Katsiki M; Marinou D; Mavrouli M; Vrioni G; Tsakris A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106211. PubMed ID: 33172591
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae.
    López-Camacho E; Paño-Pardo JR; Sotillo A; Elías-López C; Martínez-Martínez L; Gómez-Gil R; Mingorance J
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):162-166. PubMed ID: 30297092
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Hagiya H; Aoki K; Akeda Y; Yamamoto N; Shanmugakani RK; Ishii Y; Tomono K
    Microb Drug Resist; 2019; 25(6):839-845. PubMed ID: 30835635
    [No Abstract]   [Full Text] [Related]  

  • 75. Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.
    Bhowmick T; Weinstein MP
    Infect Dis Ther; 2020 Dec; 9(4):757-767. PubMed ID: 33017041
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    Zhou C; Wang Q; Jin L; Wang R; Yin Y; Sun S; Zhang J; Wang H
    Front Microbiol; 2020; 11():533209. PubMed ID: 33193122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genome-based analysis of Carbapenemase-producing
    Becker L; Kaase M; Pfeifer Y; Fuchs S; Reuss A; von Laer A; Sin MA; Korte-Berwanger M; Gatermann S; Werner G
    Antimicrob Resist Infect Control; 2018; 7():62. PubMed ID: 29744043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clonal dissemination of multilocus sequence type 11 Klebsiella pneumoniae carbapenemase - producing K. pneumoniae in a Chinese teaching hospital.
    Sun K; Chen X; Li C; Yu Z; Zhou Q; Yan Y
    APMIS; 2015 Feb; 123(2):123-7. PubMed ID: 25257726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.